# Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers

> **NCT00020878** · PHASE2 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 21 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** celecoxib

## Key facts

- **NCT ID:** NCT00020878
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2002-11
- **Final completion:** 2009-05
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00020878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00020878, "Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00020878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*